Peran Brain Stimulation TMS Pada Prajurit Penderita Depresi Yang Penugasan di Kapal Perang
DOI:
https://doi.org/10.30649/htmj.v19i1.80Keywords:
Depresi – BDI / HDRS - Prajurit - TMSAbstract
Abstract
Military personnel have a high risk of suffering from depression due to the nature of their work and training, separation from family, carrying out military missions, changing tasks, assignments in narrow places (warships) and being exposed to dangerous events and equipment. In a study by Al-Amri et al., in Saudi Arabia by taking 357 random samples, it was found that the prevalence of depression was 17.1% in an area of military operations in the Middle East. PDSKJI (2017) reports that 3.7% of the population in Indonesia suffers from depressive disorders. This study is a case report pre and post test design as many as 4 patients of naval soldiers who have been diagnosed with major depressive disorder who will receive standard therapy in the form of antidepressants and psychotherapy. First, an assessment of the level of depression was carried out using the BDI (Beck Depression Inventory) and HDRS (Hamilton Depression Rating Scale). Standard therapy for depression was given to both groups and one group plus TMS augmentation therapy, power adjusted to RMT (resting motor threshold), TMS therapy protocol with amplitude 100% high frequency 18 Hz, 2 sec with inter-train intervals of 20 sec, 55 and 59 train for 20 minutes 5 times a week. From the results of this study, clinically all patients who received TMS augmentation showed better clinical results starting from the first week of therapy with a decrease in BDI scores of 15 points and HDRS scores of 14 points. Scores decreased by a difference of 6-8 points on the BDI scale and a difference of 5-7 on the HDRS scale in patients receiving standard therapy compared to those receiving standard therapy and TMS augmentation.
Keywords : Depression – BDI / HDRS - Soldier - TMS
References
Al-Amri, M. and Al-Amri, M.D.,. Prevalence of depression and associated factors among military personnel in the air base in Taif region, in American J of Research 2013
Levkovitz, Y.,et al., 2015. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial ,in J.World Psychiatry, 14(1), 2015 p.64-73.
Laurie.B.Slone ,PhD , Matthew J.Friedman PhD, After the war zone, Da Ca Po Press, Philadelphia.2008 p1-10
Kessler RC, Berglund P, Demler O et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095 105.
Greden JF. The burden of disease for treatment-resistant depression. J Clin Psychiatry 2001;62(Suppl. 16):26-31.
Padberg F, George MS. Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression. Exp Neurol 2009;219: 2-13.
Fitzgerald P. Is it time to introduce repetitive transcranial magnetic stimulation into standard clinical practice for the treatment of depressive disorders? Aust N Zeal J Psychiatry 2003;37:5-11.
Zangen A, Roth Y, Voller B et al. Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol 2005;116:775-9.
Roth Y, Zangen A, Hallett M. A coil design for transcranial magnetic stimulation of deep brain regions. J Clin Neurophysiol 2002; 19:361-70.
Roth Y, Pell GS, Chistyakov AV et al. Motor cortex activation by H-coil and figure-8 coil at different depths. Combined motor threshold and electric field distribution study. Clin Neurophysiol 2014;125:336-43.
Harel EV, Rabany L, Deutsch L et al. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: an 18-week continuation safety and feasibility study. World J Biol Psychiatry 2014;15:298-306.
Isserles M, Rosenberg O, Dannon P et al. Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. J Affect Disord 2011;128:235-42.
Levkovitz Y, Harel EV, Roth Y et al. Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimul 2009;2:188-200.
Levkovitz Y, Roth Y, Harel EV et al. A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation. Clin Neurophysiol 2007;118:2730-44.
George MS, Lisanby SH, Avery D et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 2010;67:507-16.
Herwig U, Fallgatter AJ, H€oppner J et al. Antidepressant effects of augmentative transcranial magnetic stimulation: randomized multicentre trial. Br J Psychiatry 2007;191:441-8.
O’Reardon JP, Solvason HB, Janicak PG et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007;62:1208-16.
George MS, Nahas Z, Molloy M et al. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry 2000;48:962-70.
